Traditional cancer therapeutics, such as chemotherapies, are often limited by their non-
specific nature, causing harm to non-malignant tissues. Over the past several decades …

Cancer immunotherapy can effectively inhibit cancer progression by activating the
autoimmune system, with low toxicity and high effectiveness. Some of cancer …

Recently, nanoparticle-based drug delivery systems have been widely used for the
treatment, prevention, and detection of diseases. Improving the targeted delivery ability of …

Poly (lactic‐co‐glycolic acid)(PLGA) nanoparticles (NPs) are commonly used for drug
delivery because of their favored biocompatibility and suitability for sustained and controlled …

With the development of nanotechnology, nanoparticles have emerged as a delivery carrier
for tumor drug therapy, which can improve the therapeutic effect by increasing the stability …

Nanomedicine research has advanced dramatically in recent decades. Nonetheless,
traditional nanomedicine faces significant obstacles such as the low concentration of the …

Mesenchymal stromal cells (MSCs) currently constitute the most frequently used cell type in
advanced therapies with different purposes, most of which are related with inflammatory …

Cell membrane-coated nanoparticles are emerging as a new type of promising
nanomaterials for immune evasion and targeted delivery. An underlying premise is that the …

Mesenchymal stem cells (MSCs) are adult stem cells owing to their regenerative potential
and multilineage potency. MSCs have wide-scale applications either in their native cellular …

Extracellular vesicles (EVs) can transfer intercellular messages in various (patho)
physiological processes and transport biomolecules to recipient cells. EVs possess the …